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Abstract 
Background: Preterm birth remains a burden globally and survival has increased. 
Motor and cognitive impairment are sequelae associated with prematurity and 
prediction of long-term neurological outcome is important to parents and professionals. 
The aim of the study was to determine the accuracy of the simple and commonly used 
method of qualitative cranial ultrasound (CUS) in predicting the future, and then see if 
simple quantitative measures of brain structure using CUS would improve predictive 
power. I thus first carried out a meta-analysis of available data to determine the value 
of qualitative CUS. I then tested the accuracy of CUS measures of the corpus 
callosum and lateral ventricles, structures that would reasonably be expected to reflect 
brain connectivity or tissue loss respectively, comparing them to Magnetic Resonance 
Imaging (MRI) of the same infant. Having defined simple CUS measures that 
accurately reflected neuroanatomy as defined by MRI, I looked to see if these 
predicted neurodevelopmental outcome.  
Methods: Preterm infants born before 33 weeks gestation, raging from 24+0 to 32+6 
(mean 30+0), birth weight mean 1.36 kg (range, 0.58 to 2.6) had contemporaneous 
CUS and MRI performed at a mean postmenstrual age of 42+4 (range, 38+0 to 52+6) 
weeks. Linear measurements of the corpus callosum and lateral ventricles were 
compared using reduced major axis regression. 301 infants were included in the study, 
11 did not have complete data; therefore 290 infants with CUS/MRI pairs were 
included in the analysis. Bayley scale of infant and toddler development was 
performed at a mean corrected age of 20 months (range, 18 to 24).  
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Results: There was a strong linear relationship between the CUS and MRI 
measurements of the length of the corpus callosum and the lateral ventricles. However 
these linear measurements were not found to be good discriminators of 
neurodevelopmental impairment.  
Conclusion: Although CUS precisely measures the length of the corpus callosum and 
lateral ventricles; it was not useful at predicting neurodevelopmental outcome at 2 
years corrected age. 
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1 Introduction 
1.1 Epidemiology of prematurity  
The world health organisation (WHO) defines preterm birth as birth before 37 
completed weeks of gestation (Blencowe, Cousens et al. 2012). Preterm birth remains 
a burden in both the developed and the underdeveloped world and the incidence is on 
the increase (Tucker and McGuire 2004). An estimated 14.9 million births globally are 
preterm; over 78% occur in Africa and Asia and about 5% in Europe (Blencowe, 
Cousens et al. 2012). In 2006, the United States of America reported an increased 
incidence to 12.7% from 12.5% in 2004 (Hamilton, Martin et al. 2006) and in the years 
1981 and 2000, it reported an increase in births before 32 completed weeks gestation 
from 1.81 to 1.93% respectively (Mathews, Minino et al. 2011).  
Survival of extremely preterm infants has increased to between 50-70% in the past 
decade and this has contributed to the neurodevelopmental sequelae that are now 
evident (Wood, Costeloe et al. 2005; Marlow, Hennessy et al. 2007; Allin, Walshe et al. 
2008; Kobaly, Schluchter et al. 2008; Larroque, Ancel et al. 2008). In the early 1990s, 
an All Wales Perinatal Survey reported survival to 1 year of age of 35% in infants born 
between 24 to 25 weeks gestation, 75% in those born between 27 and 28 weeks 
gestation and 95% in those born between 30 to 31 weeks gestation (Cartlidge and 
Stewart 1997; Doyle 2001). Survival markedly improves with increasing gestational 
age at birth (Lefebvre, Glorieux et al. 1996; Cartlidge and Stewart 1997; Magowan, 
Bain et al. 1998; Doyle 2001).  
Preterm birth is associated with problems with brain development, particularly in those 
born before 32 completed weeks. The outcome of preterm birth over the past two to 
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three decades has been influenced by many changing factors, including advances in 
obstetric and neonatal care. Use of antenatal steroids, early administration of 
surfactant, changes in resuscitation techniques and ventilation strategies, and 
reduction in the use of postnatal steroids have all played a critical role in managing the 
burden of preterm birth and its sequelae (Wen, Smith et al. 2004; Zeitlin, Ancel et al. 
2010).   
Cerebral palsy, a disorder of movement and posture caused by a non-progressive 
disorder or lesion in the developing brain, is one of the sequelae often reported in 
infants and children born preterm (Bax 1964; Palmer 2004; Bax, Goldstein et al. 2005). 
The incidence is variable: some report an increase, others a plateau, while others 
report a condition on the decline (Larroque, Breart et al. 2004; Platt, Cans et al. 2007; 
Robertson, Watt et al. 2007; Wilson-Costello, Friedman et al. 2007; Hack and Costello 
2008; Surman, Hemming et al. 2009). The prevalence of cerebral palsy has an inverse 
relationship to gestational age at birth (Moster, Lie et al. 2008). This is confounded by 
many factors: preterm prolonged rupture of membranes (PPROM), spontaneous 
labour and multiple pregnancies (Nelson and Ellenberg 1985). In addition, these risk 
factors account ¼ (7.1 - 35.2%), ½ (23.4 - 64.1%) and 10% of the cases of cerebral 
palsy respectively (Ward and Beachy 2003). Although many of these are currently 
unpreventable, improvements in obstetric and neonatal care have led to increased 
survival of these vulnerable infants. However, a more in-depth understanding of the 
impact of preterm birth on brain growth and development, and specific early markers of 
aberrant brain growth and development, are required in developing strategies to 
minimise or prevent adverse neurodevelopmental outcome.  
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Cognitive impairment in preterm born children is variable and may go undetected for a 
period. The timing of the diagnosis and the different tools with which the diagnosis is 
made, affect its recognition. In addition, plasticity of the neonatal brain and 
environmental factors, affect the final neurodevelopmental outcome. Therefore, 
neurodevelopmental tests need to be able to detect those with or at risk of 
neurodevelopmental problems. Bayle Scales of Infant and Toddler Development 
(BSID) third edition is used to detect those at risk of developmental delay in children 
up to 3 years corrected age.  
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1.2 Brain development 
Brain development starts early in gestation. About days 16 to 21 post-conception, the 
neural plate forms and develops into a neural tube, from which neurons and glia cells 
form. As illustrated in figure 1, the neural tube differentiates in the fourth and seventh 
weeks of gestation into primary and secondary brain vesicles respectively. Primary 
and secondary cerebral fissures form between the 21st and 40th weeks of gestation. 
Fig 1 Embryonic Brain Development 
 
 
 
 
  
 
1.3 Microscopic brain development 
The neural plate is lined by progenitor cells, from which neurons and glia cells arise. 
The first 16 weeks of gestation are characterised by generation and proliferation of 
nerve cells. The glia cells, initially produced in the germinal matrix, are later produced 
in the sub-ventricular zone and start to multiply from around 20 weeks gestation. 
Cellular development of the brain goes through three main stages:  
1  Proliferation of nerve cells, which mainly occurs in the second trimester 
2 Neuronal migration, under radial glia cell guidance, begins from the epithelium and 
goes through the cerebral hemispheres to form the cortex as demonstrated in figure 2 
Fig 1: Embryonic development of the brain showing primary and secondary neurulation (en.wikipedia.org) 
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below. The earliest cells, which form the pre-plate, lie at the outer margins of the 
cerebral hemispheres. The pre-plate further divides into a subplate, which forms the 
innermost layer and marginal zone on the outside. These neurons further migrate to 
form the cortical plate, which lies between the marginal zone and the subplate. The 
subplate neurons develop dendritic projections, which connect the thalamus to the 
cortex. Through the process of apoptosis, redundant neurons are removed from the 
cell line and only those that survive, integrate into the neural system; this process 
begins late in the third trimester (Ghosh and Shatz 1993; Blakemore, Crang et al. 
1995; Volpe 2001). 
3 Finally, insulation of the neurons by the fatty myelin sheath and formation of 
synapses with target organs occurs (Tomaselli, Neugebauer et al. 1988).  
Fig 2 Stages of fetal cortical development   
 
 
 
1.3.1 Glia and oligodendrocyte development 
Oligodendrocytes are the predominant glia cells in the white mater. As illustrated in 
figure 2 above, they develop in 4 stages: oligodendroglial progenitor (OP) cells 
generate from ventricular (V) and sub-ventricular zones (SV), and differentiate into 
preoligodendrocytes during their migration through the cerebral white matter. 
Fig 2: A schematic representation of four stages in the 
foetal development of cortical lamination in the cerebral 
wall.  Abbreviations: V, ventricular zone; PP, pre-plate; IZ, 
intermediate zone; SV, sub-ventricular zone; SP, sub-plate; 
CP, cortical plate; MZ, marginal zone (Uylings 1990) 
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Preoligodendrocytes, which are present from 18 weeks to near term, differentiate into 
immature oligodendrocyte. Immature oligodendrocytes later differentiate into mature 
oligodendrocytes (Back, Luo et al. 2001).  
1.3.2 Myelination 
Myelin is laid down closest to the oligodendrocyte cell body and extends down the 
axon (Bologa 1985). Myelination occurs in an orderly fashion: central to peripheral, 
caudal to rostral and dorsal to ventral. The brainstem myelinates early and by 32 to 36 
weeks of gestation, the posterior limbs of the internal capsule begin to myelinate. 
Myelination of the corticospinal tracts of the precentral and the postcentral (primary 
somatosensory cortex) gyri begins at 36 to 40 weeks of gestation and completes by 
the end of the second year. The corpus callosum myelinates from 6 weeks post term 
and carries on until 10 years of age (Brody, Kinney et al. 1987). 
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1.4 Corpus callosum and lateral ventricles  
1.4.1 Growth and development of the corpus callosum 
Many studies have looked at the development of the corpus callosum, the biggest 
bundle of white matter tracts, and its effect on neurological or neuropsychological 
outcome in children, adolescents and young adults born preterm (Nosarti, Al-Asady et 
al. 2002; Nosarti, Rushe et al. 2004; Anderson, Laurent et al. 2005; Anderson, Laurent 
et al. 2006; Cascio, Styner et al. 2006; Allin, Nosarti et al. 2007). Corpus callosal 
growth in the first 2 postnatal weeks is the same as observed in foetal life, among 
preterm infants born before 33 weeks gestation; the growth then dramatically slows 
down between the 2nd and the 6th postnatal weeks (Anderson, Laurent et al. 2005; 
Anderson, Laurent et al. 2006). For many years, the callosal growth was thought to be 
in the antero-posterior direction. The genu, anterior part of the corpus callosum, was 
believed to be the first to develop and the first to stop growing; while the posterior 
regions, appeared later and continued to grow until young adulthood. The rostrum, 
which lies anterior to the genu, was thought to appear last. The first evidence of the 
anterior corpus callosum appears on weeks 14 to 15 post conception and the posterior 
parts develop on weeks 18 to 19. Recent fetal imaging data suggest that callosal 
development begins more centrally in the hippocampal primordium and grows antero-
posteriorly (Giedd, Rumsey et al. 1996; Giedd, Blumenthal et al. 1999; Harreld, Bhore 
et al. 2011).  
1.4.2 Functional connectivity of the corpus callosum 
The genu has the highest density of thin and slow conducting callosal fibres, while the 
anterior midbody comprises of larger but not so densely packed axons. The posterior 
midbody is made up of large and highly conductive fibres and the anterior splenium is 
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made up of thin and densely packed fibres, like the genu. The posterior splenium is 
made up of large highly conductive fibres, like the anterior midbody. The isthmus, 
which connects the body of the corpus callosum to the splenium and forms its thinner-
most part, is made up of medium sized fibres. This topography gives an impression of 
bidirectionality in the development of the corpus callosum. The anterior parts of the 
corpus callosum connect the prefrontal association, premotor, supplementary motor 
and the antero-inferior parietal areas; the posterior midbody and isthmus connect the 
primary motor and sensory cortex and the anterior splenium connects the parietal and 
temporal lobes while the posterior splenium connects the occipital lobes. All callosal 
fibres are present at birth and increase their functional connectivity with increasing 
myelination over time (Giedd 1999). 
1.4.3 Embryology of the lateral ventricles 
The cerebral ventricular system develops from the neural canal and is the brain’s 
drainage system. It comprises of two lateral ventricles, 3rd and 4th ventricles through 
which the cerebrospinal fluid (CSF) flow. The CSF is produced by the choroid plexus, 
which lies within the body of the lateral ventricles extending to the temporal horn; 
frontal and occipital horns do not contain choroid plexus. The development of the 
choroid plexus is largely complete by 22 weeks of gestation. The neural canal dilates 
within the prosencephalon, forming the lateral and third ventricles; dilatation within the 
rhombencephalon forms the fourth ventricle. The cerebral aqueduct is formed by the 
dilatation within the mesencephalon. In relation to cerebral size, the ventricles are the 
biggest early in gestation. About 15 weeks gestation, the lateral ventricular width is 
about two thirds of the cerebrum and by 20 weeks gestation it is about a third of the 
cerebrum. 
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1.4.4 Pathophysiology of ventricular dilatation 
Ventricular dilatation remains without a unified diagnostic criterion among 
neonatologists. In addition to the diagnostic criteria, the underlying pathology is just as 
important in determining future prognosis. The underlying causes can roughly be 
categorized into disturbances in cerebrospinal fluid (CSF) production or absorption and 
white matter disease leading to white matter loss. Central to ventricular dilatation is 
impaired myelination secondary to white matter damage. A better understanding of 
ventricular dilatation would lead to improvements in prediction, prevention, and 
intervention strategies and therefore potential improvement in prognosis. 
 
 
 
 
 
 
 
 
 
 
 26 
1.5 Preterm brain injury 
Normal developmental processes are interrupted or disrupted by preterm birth and 
postnatal events, leading to development of potentially devastating co-morbidities. The 
outcome to perinatal insult/s depends on the timing, nature, site, and severity of the 
injury. Injury to the subplate may disturb important synaptic links between the cortex 
and the subcortical structures. The preterm brain is therefore particularly vulnerable to 
injury at a critical time in development.  
Intraventricular haemorrhage (IVH) is the commonest form of recognised brain injury in 
preterm infants. In spite of improvements in neonatal care, the incidence of IVH 
remains static (Jain, Kruse et al. 2009). In extreme prematurity, the incidence is still 
about 45% with potentially devastating outcome (Wilson-Costello, Friedman et al. 
2005). Severity of IVH affects morbidity as well as mortality (Pinto-Martin, Whitaker et 
al. 1999; Whitelaw 2001; Murphy, Inder et al. 2002; Payne, Hintz et al. 2013).  
Periventricular white matter injury is a spectrum. The diffuse form, diffuse excessive 
high signal intensity (DEHSI) is often recognised on magnetic resonance imaging 
(MRI); however this form of diffuse white mater disease is not often recognised on 
cranial ultrasound (CUS). Focal white matter injury, in the form of cystic periventricular 
leukomalacia (cystic PVL), although reduced in incidence in modern neonatal care, is 
reliably detected on CUS. Haemorrhagic parenchymal infarction (HPI), like other focal 
white matter insults, is easily detected on CUS and may affect normal motor 
development if the corticospinal tracts are compromised. Although white matter injury 
is the most recognised injury on CUS, the cortex, subcortical region and deep grey 
matter are also affected in perinatal brain injury. Thalamic injury though not commonly 
reported in preterm brain injury is identified by MRI more often than by CUS (Leijser, 
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Klein et al. 2004). It is often seen in children who suffered significant white matter 
injury, suggesting that important networks are disrupted by preterm birth (Boardman, 
Counsell et al. 2006).  
Cranial ultrasound (CUS) has been the main tool used in diagnosis of clinically 
significant brain changes in neonatal units since the late 1970’s, in spite of its varied 
use and interpretation in clinical practice (Reynolds, Dale et al. 2001; Davis, Cox et al. 
2005; Hagmann, Halbherr et al. 2011). The main advantage of CUS is portability, 
which allows it to be performed by the bedside with minimal disturbance to the infant 
and can be easily repeated according to clinical need. There is a large literature 
available on its prognostic value (De Vries, Van Haastert et al. 2004; Ancel, Livinec et 
al. 2006; Kuban, Allred et al. 2009), unlike brain MRI, which remains largely a research 
tool with an increasing body of literature.  
MRI is a safe, non-invasive, and non-ionising technique for imaging the developing 
brain. It is sensitive to both physiological and pathological changes within the newborn 
brain, making it ideal for investigating the developing brain. It is however, expensive 
and requires transfer to an imaging department or centre. Conventional MRI gives 
anatomically richer data and detects subtle white matter changes more accurately than 
CUS (Debillon, N'Guyen et al. 2003; Inder, Anderson et al. 2003; Mirmiran, Barnes et 
al. 2004; de Vries and Cowan 2007; Horsch, Hallberg et al. 2007); however prognostic 
implications of these are not always apparent. MRI is yet to be used routinely in the 
care of the preterm infants. Although MRI was previously thought to be better than 
CUS in predicting long-term outcome, evidence that supports this is weak (Mirmiran, 
Barnes et al. 2004; Woodward, Anderson et al. 2006). For this reason, MRI is still 
largely used as a research tool. While novel MRI analyses that could be clinically 
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useful are being developed, attempts at improving the diagnostic capability of both 
CUS and MRI are required. MRI however is not readily available in most neonatal 
units, unlike CUS. There remains a challenge therefore to find an ultrasound measure 
of white matter disease that is comparable to MRI.  
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1.6 Imaging of preterm brain injury using 2D CUS 
1.6.1 Physical properties of CUS 
Ultrasound forms images by calculating the time taken by the sound wave (longitudinal 
wave) to travel from transducer to the reflective surface (tissue or organ). Ultrasound 
waves require a medium (gas, solid or liquid) to be transmitted. This transmission 
occurs by a sequence of compressions and rarefactions within the conducting medium 
as demonstrated in fig 3.  
Fig 3   Sound wave travel through air 
 
 
 
A longitudinal wave transmits its energy through material by causing the molecules in 
its path to oscillate back and forth, parallel to the direction of travel of the wave. The 
pressure force exerted on first contact with the first particle causes the particle to 
acquire a velocity. The second particle receives the force from the first and with the 
force having been transferred, particle one returns to its original position. Particle two’s 
displacement is slightly smaller than that of particle one, due to loss of heat energy 
within the bonds, so the signal energy gradually decays. This phenomenon is then 
repeated for the remaining particles, causing the original energy to be transported 
across particles by compression and rarefaction events as the particles oscillate to and 
Fig 3: Longitudinal movement of sound waves in air causing 
oscillations as the original energy is being transported across 
particles by compression and rarefaction. The distance 
between the repeated compressions is the wavelength 
(google)    
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fro. During travel through the tissue, the oscillations lose energy as heat and the wave 
amplitude decreases, while frequency and wavelength are unaltered. 
Frequency and wavelength are related as follows: f = v /λ  
Where v is the speed of sound in the medium (tissue, bone, air, etc) measured in 
meters per second (ms-1), λ wavelength and f frequency of oscillation in cycles per 
second (Hz). The excitation in the medium propagates with the velocity specific to the 
material; it is slowest in gases and fastest in solids. This is not directly related to 
material density but is a reflection of molecular bond stiffness (compressions) or 
springiness (rarefaction).  
The transducer produces ultrasound pulses (intermittent pulse waves) formed of 2 to 3 
cycles per pulse, all at the same frequency. The ultrasound transducer contains 
piezoelectrical ceramic element, lead zirconate titanate, which plays part in the 
conversion of electrical energy to mechanical and vice versa. It therefore has two main 
functions, firstly to generate pulse waves sent to the target organ or tissue and 
secondly to receive returning echoes from the target organ or tissue. The returning 
echoes are then converted to electrical signals; which are in turn converted and 
formatted in the scan convertor into an image. These formatted images are then 
viewed in a video monitor of the ultrasound computer screen.  
Each image is made up of pixels. Each pixel represents amplitude of the returning 
echoes. There are different signals corresponding to different pixels. Imaging data are 
processed and digitalised according to signal strength. Gray-scale display represents 
echo signal strengths. The number of pixels depends on the size of the matrix. Each 
pixel is designated a shade of gray depending on its value; it is the sum of all the 
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shades of gray that forms the image. In addition, pixel depth influences displayed 
image contrast. The typical pixel depths are: 6 bits or 26 giving 64 gray scales, 7 bits or 
27 giving 128 gray scales and 8 bits or 28 giving 256 gray scales (Kossoff 2000). 
1.6.2 Optimising performance 
There has been a marked improvement in the cranial ultrasound (CUS) image quality 
over the past three decades. Modern CUS scanners use multi-frequency transducers, 
5 to 10MHz. High frequency transducers, usually with a frequency of 7.5MHz, have 
high resolution and better imaging quality. Frequencies of 10MHz are better at 
visualising superficial structures; however loss of penetration is a limitation. Low 
frequency transducers, usually with a frequency of 5MHz, have a better penetration to 
deeper structures at the expense of resolution. Focus point may also be used for 
better visualisation of a target area. 
Choosing the correct transducer is critical; ideally it should fit well within the fontanelle 
in order to avoid loss of signal in the more peripheral areas. Phased array (PA) probes 
have ultrasound beams starting at a point but then diverge; this is limiting for far field 
viewing. Convex probes increase the field of view and therefore allow better 
visualisation of distant and near field structures. The anterior fontanel (AF) is 
frequently used for routine CUS imaging in neonatal care. A gel is applied on the skin 
in order to promote conductivity of the sound waves through the skin. The images are 
taken in at least 6 coronal and 5 sagittal planes and any suspected lesions should be 
viewed in both planes.  
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1.7 Imaging of the brain using MRI 
Unmyelinated cerebral white matter appears as high signal on T2W and low signal on 
T1W images. The white matter has bands of low and high signal intensity found in the 
periventricular areas, which are thought to represent regions of migrating glial cells 
from the germinal matrix to the cerebral cortex. This appearance becomes less evident 
with increasing gestation (Felderhoff-Mueser, Rutherford et al. 1999). 
1.7.1 Physical properties of MRI 
The human body contains water and therefore has an abundance of hydrogen nuclei 
(single protons), which in the absence of external magnetic field are randomly 
orientated. When a static magnetic field is applied, the hydrogen nuclei assume an 
orientation parallel or anti-parallel to the orientation of the direction of the applied 
magnetic field. The static polarising magnetic field is called B0 field. As demonstrated 
in figure 4, the direction parallel to B0 is termed the longitudinal direction or z and the 
direction perpendicular to B0 is termed the transverse or xy plane. When the nuclei 
polarisation is no longer aligned with the static magnetic field, it changes its orientation 
to the direction of the imposed magnetic field; this is called precession. The rate of 
precession is dependent upon the orientation of the nuclei and the magnetic field 
strength. This relationship is expressed as the Larmor equation:   
ω = γB0 
Where ω is the Larmor frequency, measured in megahertz (MHz), γ is the 
gyromagnetic ratio of the nucleus and B0 is the magnetic field in Tesla (T). For protons 
γ = 42.6 MHz/T and so for a 1 Tesla field, Larmor precession frequency is 42.6 MHz.  
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 Fig 4  Properties of Magnetic Resonance Imaging 
 
 
If an oscillating field, B1, also called radiofrequency (RF) is imposed on a group of 
protons in a static magnetic field, the interaction is called magnetic resonance. RF 
energy is absorbed from the transmitter coil, causing polarisation or net magnetic 
vector (NMV), rotating the polarisation from the direction parallel to the static magnetic 
field to that determined by the angle, strength and duration of the RF. If a 900 pulse is 
applied, the NMV is rotated from a longitudinal (B0) to a transverse plane, this induces 
an electromotive force (EMF) in a receiver coil, which produces a measurable signal 
that can be recorded and stored for further analysis. The measured signal, decays 
over time as the spins lose phase coherence and this is called the free induction decay 
(FID).  
1.7.2 Relaxation 
After application of the RF pulse, the NMV returns to equilibrium, this is called 
relaxation phase. Relaxation is the basis of image contrast in conventional MR 
imaging. There are two relaxation processes. T1 recovery is the process by which 
Fig 4: The main direction of the magnetic field 
represented by B0 with z representing the 
longitudinal direction, x and y the transverse 
directions of the magnetic field (Pooley 2005) 
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longitudinal magnetization is restored after a RF pulse. T1 is defined as the time taken 
for 63% of the total longitudinal magnetisation to recover alignment to B0 as depicted 
in figure 5 below. 
Fig 5 Definition of T1 weighting                     Fig 6 Definition of T2 weighting                                                                                                  
                                
Fig 5: T1 as the time taken for 63% of the total longitudinal           Fig 6: T2 as the time taken for 37% of the total transverse 
magnetisation to recover (Pooley 2005)                                         magnetisation to decay (Pooley 2005) 
T2 relaxation is a time taken by the transverse magnetisation to decay (spin-spin 
relaxation) to 37% of its original value as shown in fig 6. The transverse relaxation time 
(T2) of solids is very short as they contain fixed molecules, which maintain local field 
variations and is longer in liquids. As the transverse magnetisation decays with time 
constant T2*, the induced voltage and hence MR signal, decays with the same 
constant. 
1.7.3 The MR signal 
If following a 900 RF excitation pulse, another is applied that flips the dispersed 
magnetisation by 1800; magnetisation evolves, causing regeneration of phase 
alignment, so that the signal is partially restored, leaving T2 decay as the remaining 
mechanism for signal loss. If there is a delay of τ between the initial RF excitation of 
the transverse magnetisation and the application of an 1800 pulse, full signal recovery 
occurs after another delay of τ. This time period of 2τ is called echo time, TE. The 
signal changes as follows during this process:  
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a) Following a 900 excitation pulse, a FID is generated that decays with time constant 
T2* 
b) The 1800 pulse refocuses the spins, and the signal is at maximum at time TE 
c) The signal decays again as the spins dephase. By applying other 1800 pulse a train 
of echoes is created. Each echo decays with time constant T2* due to static field 
inhomogeneities. 
Fig 7 Formation of spin echo 
 
 
1.7.4 Image contrast 
The main determinants of image contrast are the flip angle, the rotation of the 
longitudinal magnetisation about the transverse plane, the echo time (TE) and 
repetition time (TR), which is the time between excitations. TE dictates dephasing of 
the transverse magnetisation while TR dictates the extent of the longitudinal 
magnetisation recovery and hence residual magnetisation for the next excitation.  
 
Figs 7: Spin echo formation. TE refers to echo time; FID refers to free 
induction decay (Pooley 2005) 
 36 
1.7.5 T1 weighting 
To achieve T1 weighting, a short TR, which will allow the longitudinal magnetisation to 
recover more rapidly, resulting in a greater residual magnetisation for excitation after 
each TR interval, is required. To minimise any difference in the decay of the transverse 
magnetisation, TE is kept as short as possible. This gives higher signal intensity in 
T1W images. Another way of achieving T1W images is by using inversion recovery 
sequence. Here an additional 1800 pulse is added to invert the magnetisation and 
following this inversion pulse, 900 pulse is applied to excite the longitudinal 
magnetisation into the transverse plane. The recovery of this longitudinal 
magnetisation prior to applying the 900 pulse is determined by the T1 present in the 
tissue and the inversion time (TI) used in the sequence. 
1.7.6 T2 weighting 
Unlike in the T1 weighting, in T2 weighting a longer TE is used to maximise the 
different T2 components and a long TR to allow full longitudinal magnetisation of each 
tissue to recover and eliminate T1 effects. The long TE maximises the difference 
between the rate of decay of the transverse magnetisation and the long TR to 
minimise any difference in the recovery of the longitudinal magnetisation hence 
preventing the image being T1 weighted. 
1.7.7 Proton density weighting 
Proton density weighting emphasises the density of protons per volume of water and 
fat in a voxel. Although white and gray matters have similar proton density, they are 
differentiated by their fat and water content. In proton density weighting a long TR and 
short TE are used to minimise the effects of T1 and T2 weighting respectively. A long 
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TR allows full recovery of longitudinal magnetisation and a short TE does not allow 
signal time to decay, therefore remains high thus minimises T2 effects.  
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2 Aims 
The overall aim of this study is to investigate the value of CUS in detecting MRI 
comparable white matter disease and predicting neurodevelopmental outcome. 
Study 1: Conduct a meta-analysis on the value of CUS in predicting 
neurodevelopmental outcome 
Study 2: Investigate if measurement of the corpus callosum and lateral ventricles, 
structures that would reasonably be expected to reflect brain connectivity or tissue 
loss, using CUS and MRI, are precise measures of the underlying neuroanatomy 
and whether they give comparable results 
Study 3: Determine if the measurements where CUS should be as good as MRI 
were accurate predictors of neurodevelopmental outcome 
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3 Hypothesis 
Although cranial ultrasound remains the most practical tool used in modern neonatal 
care for brain examination, it is a poor descriptor of neuroanatomy compared to MRI. 
However, there are some features of brain structure where it is reasonable to expect 
CUS to be as accurate as MRI. The aim of this study is to determine if measurement of 
the corpus callosum and lateral ventricles, structures that would reasonably be 
expected to reflect brain connectivity or tissue loss, using CUS and MRI, are precise 
measures of the underlying neuroanatomy and give comparable results.  
I used available data on the outcome of a subset of patients at around 2 years to 
determine if the measurements where CUS should be as good as MRI were accurate 
predictors of neurological outcome.  
I hypothesized that the CUS measurements of the corpus callosum can be used as a 
prognosticator of MRI defined white matter disease, so that (a) CUS measurements of 
the corpus callosum and ventricles are similar to those taken by MRI and (b) these 
measurements predict neurological outcome at 20 months corrected age. 
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Study 1 
4 Meta-analysis on CUS as predictor of long-term outcome 
4.1 CUS prediction of long-term outcome in preterm born infants 
In order to understand the value of CUS in predicting adverse outcome, I undertook a 
literature search of studies that specifically looked at how CUS predicted 
neurodevelopmental outcome to 2 years of age in preterm infants born before 33 
weeks gestation or very low birth weight infants (birth weight less than 1500 grams).  
4.2 Methods 
4.2.1 Search strategies 
I carried out the search using PubMed. The search terms were: preterm, cranial 
ultrasound and neurodevelopmental outcome. The search was limited to the age 
group, birth to 23 months. Only publications with full text in English were screened for 
relevant data.    
4.2.2 Inclusion criteria 
Studies selected for analysis were those of infants born before 33 weeks gestation or 
had a birth weight less than 1500 grams, that characterized cranial ultrasound 
changes according to commonly used clinical grading: [normal, intra-ventricular 
haemorrhage (IVH), moderate to severe ventricular dilatation, hydrocephalus, peri-
ventricular leukomalacia (PVL)] as well as having recognized developmental 
outcomes, such as cerebral palsy (CP) around 2 years corrected age.   
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4.2.3 Data extraction and analysis 
I went through each study extracting data relevant for the analysis. Where such data 
could not be extracted from the studies, authors were contacted and asked for the 
data. Where multiple reporting of data was suspected, authors were questioned and 
multiple reports excluded. Once extracted, these data were presented in a 2 x 2 table, 
and when a cell within the table contained zero, 0.5 was added on all cells in that 
study, to enable finite calculations. 
The calculations for the meta-analysis were carried out using MetaDisc software 
(Zamora, Abraira et al. 2006). MetaDisc is a dedicated meta-analysis of diagnostic 
studies software. Data input into the MetaDisc database was done manually, by typing 
the data into the dedicated spreadsheet. MetaDisc also allows importing of data from 
excel spreadsheets and text files. The data required for the analysis were true positive 
(TP), false positive (FP), false negative (FN) and true negative (TN) values; where TP 
was the number of individuals with the condition in whom the test was positive, FP 
being the number of individuals without the condition but a positive test, FN referring to 
individuals with the condition in whom the test was negative and TN being the 
individuals without the condition in whom the test was negative.   
The accuracy of each study was assessed, by calculating tests such as sensitivity (the 
proportion of positive tests among individuals with the condition), specificity (the 
proportion of negative tests among individuals without the condition), and likelihood 
ratios (the probability of a particular test result in people with the condition, to the 
probability of the same test result in people without the condition). MetaDisc presents 
calculations in tables and graphs with reported 95% confidence intervals.  
Homogeneity of data among the studies was visually assessed using forest plots. 
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Each red circle in the forest plot corresponds to the precision of the estimate and the 
horizontal blue line represents 95% confidence intervals. The red diamond at the 
bottom of the plot and the vertical dotted red lines at its edges represent the pooled 
data and 95% confidence interval respectively. When studies are homogeneous, the 
accuracy estimates lie along the line of pooled data and large deviations from this line 
of pooled data suggest heterogeneity MetaDisc determines the extent of heterogeneity 
by using I-squared (I2). I2 estimates the percentage of total variation among studies 
that is not due to chance. I2 lies between 0% and 100%.   
The equation for I2 is:  I2 = 100 x (Q - df)/Q 
Where Q is Cochran's heterogeneity statistic and df, the degrees of freedom. Q only 
tells us whether or not there is heterogeneity, but does not estimate its extent. 
Precision of I2 depends on the number of studies and should be used with caution 
when assessing large studies with clinically insignificant heterogeneity that may be 
statistically significant, and in fewer studies where power may be too low for 
heterogeneity to be detected (Higgins and Thompson 2002; Higgins, Thompson et al. 
2003; Huedo-Medina, Sanchez-Meca et al. 2006).  
We used the Bayes’ theorem to calculate the post-test probability using the formula: 
   
Where P (A): prior probability or probability before any new information is obtained 
P (B/A): conditional probability of B given A  
P (A/B): conditional probability of A given B or posterior probability (probability after 
obtaining new information) 
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P (B): prior probability of B or normalising constant 
Using the Bayes’ theorem we calculated post-test probability, the probability of 
developing cerebral palsy (CP) given a certain cranial ultrasound test result, using the 
formula:  
Post-test probability = (Pre-test probability x LR)/ [(Pre-test probability x LR) + (1-Pre-
test probability)] Where LR stands for likelihood ratio 
(www.uphs.upenn.edu/dgimhsr/documents/05.2x2.india09.pdf)    
The pre-test probability (prevalence) of cerebral palsy was estimated from the Epipage 
study (Larroque, Breart et al. 2004). I estimated the post-test probability; the 
conditional probability obtained after relevant evidence (CUS result) has been taken 
into account. Post-test probability either rules in a diagnosis (if post-test probability is 
higher than pre-test probability) or excludes it (if post-test probability is lower than pre-
test probability).  
In addition, a diagnostic odds ratio (DOR), an expression of how much greater the 
odds of having the condition are in individuals with a positive test than in those with a 
negative test, was calculated. This is a diagnostic test that combines both positive and 
negative likelihood ratios and gives a single result. It remains constant regardless of 
variations in diagnostic thresholds and corrects for heterogeneity. It is therefore the 
preferred test of accuracy in meta-analysis. It is calculated by the following formula:  
DOR = LR+  = TP x TN               
            LR-     FP x FN   
Where LR+ is positive likelihood ratio, LR- negative likelihood ratio, TP true positive, TN 
true negative, FP false positive, and FN false negative. The value of DOR ranges 
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between zero and infinity. A value of one means that the test is non-discriminatory and 
higher values mean that the test is reliable at discriminating those with the condition 
from those without (Glas, Lijmer et al. 2003).  
4.2.4 Results 
The Pubmed search yielded 1677 results on the initial search. Limiting the search by 
age (birth to 23 months) yielded 22 articles. Most of these studies did not meet the 
inclusion criteria. Full text on relevant articles in English was available in 12 studies. 
Only 7 studies that included cerebral palsy as an outcome were included in the final 
analysis. These studies comprising of 12831 infants were included in the final analysis.                                                           
A normal brain scan is highly predictive of a normal motor outcome as demonstrated in 
figures 9. 
Fig 8 Positive likelihood ratio of normal CUS in predicting cerebral palsy 
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Fig 9 Negative likelihood ratio of normal CUS in excluding cerebral palsy 
 
Fig 10 Diagnostic Odds Ratio of normal CUS in predicting cerebral palsy 
 
Table 1: Sensitivity of normal CUS in predicting cerebral palsy 
Study Sensitivity 95% confidence interval 
De Vries 0.06 0.003 – 0.012 
Stewart 1983 0.17 0.02 – 0.48 
Kuban 2009 0.43 0.34 – 0.52 
Stewart 1987 0.17 0.06 – 0.33 
Adams-Chapman 2008 0.74 0.72 – 0.76 
O’Shea 2008 0.61 0.55 – 0.67 
Ancel 2006 0.34 0.26 – 0.42 
Sensitivity is the proportion of test positives in individuals with the condition. The mean and the 95% confidence interval are 
presented for the sensitivity of each study. 
 
 
 
 46 
Table 2 Specificity of normal CUS in excluding cerebral palsy 
Study Specificity 95% confidence interval 
 
De Vries 0.26 0.23 – 0.28 
Stewart 1983 0.38 0.28 – 0.49 
Kuban 2009 0.29 0.26 – 0.32 
Stewart 1987 0.45 0.39 – 0.51 
Adams-Chapman 2008 0.12 0.11 – 0.12 
O’Shea 2008 0.26 0.23 – 0.30 
Ancel 2006 0.33 0.31 – 0.35 
Specificity is the proportion of test negatives among individuals without the condition. The mean and the 95% confidence interval 
are presented for the specificity of each study. 
The meta-analysis for the prognostic values of cranial ultrasound, with 95% confidence 
intervals is summarised in table 3. 
Table 3 Prediction of CP by cranial ultrasound 
Cerebral Palsy US test result 
Pre-test 
probability %  
Likelihood ratios 
(95% CI) 
Post test 
probability %  
(95% CI) 
Heterogeneity 
amongst studies 
 (I-squared %) 
Normal scan 9 0.5 (0.4-0.7) 5 (4-6) 90 
Grade 1 or 2 IVH 9 1 (0.4-3) 9 (4-22) 88 
Grade 3 IVH 9 4 (2-8) 26 (13-45) 82 
Grade 4 IVH (any) 9 11 (4-31) 53 (29-76) 84 
Cystic PVL 9 29 (7-116) 74 (42-92) 90 
Ventricular 
dilatation 
9 3 (2-4) 22 (17-28) 0 
Hydrocephalus 9 4 (1-13) 
 
27 (10-56) 97 
Normal scan refers to absence of haemorrhage within the brain parenchyma or ventricles, cysts or ventricular dilatation. The 
grade of IVH (intra-ventricular haemorrhage) is given according to the Papile classification. PVL= peri-ventricular leukomalacia.  
Ventricular dilatation = moderate to severe ventricular dilatation not meeting the criterion for hydrocephalus. Hydrocephalus = 
massive ventricular dilatation > 4mm above the 97th centile. Pre-test probability refers to the prevalence of cerebral palsy (CP) 
based on the Epipage study. Likelihood ratio is the probability a particular US result in patients with cerebral palsy to the 
probability of the same result in people without CP. Post-test probability is the probability of having CP after US results have been 
obtained. Heterogeneity is a measure of dissimilarity between studies and the validity of statistical pooling. 
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4.3 MRI prediction of long-term outcome in preterm born infants 
A similar literature search to that on CUS studies was carried out on how brain MRI 
predicted neurodevelopmental outcome to 2 years of age in preterm infants born 
before 33 weeks gestation or very low birth weight infants (birth weight less than 1500 
grams). It was difficult to carry out a meta-analysis due to fewer studies meeting the 
inclusion criteria. 
4.4  Conclusion 
A normal CUS was confidently predictive of normal motor outcome. Although cystic 
parenchymal changes on CUS were predictive of CP, the wide confidence limits 
however made it difficult to confidently draw conclusions. The meta-analysis was 
characterised by marked heterogeneity and the imaging findings had wide confidence 
limits. This observation suggested that for individual patients, there remains a need to 
find methods of CUS detection of white matter disease comparable to MRI. This 
analysis has been published and is included as an appendix (Nongena, Ederies et al. 
2010). 
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Study 2 
5 Subjects 
This sample was recruited as part of a large National Institute for Health Research 
(NIHR) funded programme grant study, ePrime (evaluation of MRI to predict 
neurodevelopmental impairment in preterm infants). The cohort comprises of preterm 
infants born before 33 weeks gestation from the North and South West London 
Perinatal Networks over 3 years. A sample of 301 infants was collected over 2 years. 
493 infants were eligible for screening, 63 were still in-patients at the time of scanning 
and could not travel to the imaging centre (Hammersmith Hospital). In addition, 112 
participants declined consent, 12 died and 5 withdrew consent. 
Table 4 Subject characteristics 
Characteristics Mean Range 
BW (kg) 1.36 0.58 – 2.6 
GA (weeks) 30+0 24+0  – 32+6 
PMA (weeks) 42+4 38+0  – 52+6 
CA (months) 20 18  – 24 
BW stands for birth weight, CW stands for current weight, GA stands for gestational age at birth, PMA stands for postmenstrual 
age, CA stands for corrected age. 
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Fig 11 Consort diagram 
 
∗ Only participants attending the imaging centre, at Hammersmith hospital, on an outpatient basis were included in the study, as 
they were considered well enough to undergo MRI.  
 
5.1 Study approval and patient consent 
The Hammersmith, Queen Charlotte’s and Chelsea research ethics committee 
approved the ePrime study from which the cohort was obtained. The ePrime study 
ethics reference number is 09/H0707/98 and the EudraCT number is 2009-011602-42. 
The ePrime study is funded by the UK National Institute for Health research (NIHR) 
and Imperial College London is the sponsor. Signed informed consent was obtained 
from the parents of the children taking part in the study.  
 
 
Eligible 
infants 
N=493 
Included N=301 
CUS & MRI 
N=290 
CUS/No MRI 
N=11 
Not settled for 
MRI N=5 
Movement 
artefact N=6 
Excluded 
N=192 
Declined 
consent 
N=112 
Died or withdrew 
consent before 
MRI N=17 
*Still 
inpatients 
N=63 
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5.2  Sedation, immobilisation and patient safety 
5.2.1 Sedation and immobilisation 
Chloral hydrate sedation was routinely offered at a dose of 30-50mg/kg/dose with 
parental consent. For those who declined consent to sedation, the infant was 
encouraged to naturally sleep following a feed. Immobilisation of the infants during MR 
imaging was achieved by using polystyrene beads containing vacuum bag, which was 
evacuated with a suction to fit snugly around the infant’s head and body. 
5.2.2 Patient safety  
All infants were dressed in metal free clothes and a metal check examination was 
performed before the patient is put onto the magnetic resonance (MR) table. This was 
done to prevent potential risk of projectile injury from the static field on ferromagnetic 
objects within the vicinity of the magnetic field. Repetitive radiofrequency (RF) pulses 
may also result in radiofrequency heating effects, which may result in minor burns 
where tissues come into contact with such objects (as implanted metallic devices).  
All infants had their heart rate, temperature and oxygen saturation observed by a 
paediatrician (PN) or paediatric nurse during the MR scanning. Heart rate monitoring 
was achieved by attaching electrocardiographic (ECG) leads onto the infant’s chest 
wall; temperature by placing an MR-compatible temperature probe high in the axilla 
and oxygen saturation monitoring by placing an MR-compatible saturation probe onto 
the infant’s foot. Monitoring of vital signs continued until the infant was fully awake and 
ready for discharge. 
All infants had ear protection, comprising of earplugs made of individually molded 
silicone-based putty (President putty, Coltene/Whaledent, 750 Corporate Drive, 
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Mahwah, New Jersey, USA), placed on the outer ear canal and neonatal earmuffs 
(Natus MiniMuffs, Natus Medical, San carlos, Carlifonia, USA) (Merchant, Groves et al. 
2009). CUS examination is safe. 
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6 Methods 
I compared linear measurements of the corpus callosum and the lateral ventricles 
using both MRI and CUS. The length of the corpus callosum was measured linearly 
from the genu to the splenium in the sagittal view as shown in figures 12 and 13. 
 
 
 
 
Using the method by Witelson, the corpus callosum was divided into the anterior 
third, anterior midbody, posterior midbody, isthmus and splenium (Witelson 1985). 
The genu width was taken as its horizontal antero-posterior distance and the 
splenial width as its horizontal antero-posterior distance at the splenium. I 
measured the depth of the corpus callosum at the anterior midbody, as the vertical 
distance from its superior to its inferior borders; this is demonstrated in figures 14 
and 15.  
Fig 12: CUS Measurement of the length of the 
corpus callosum 
Fig 13: T1 weighted MRI in mid-sagittal view 
showing a linear measurement entire length of 
the corpus callosum 
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The anterior horn width was measured in the mid-coronal plane at the level of the 
foramen of Munro, just anterior to the choroid plexus. It was taken at the widest point 
from the floor of the ventricle to the medial ventricular wall, as shown in figures 16 and 
17. 
 
 
 
The measurement of the midbody height was taken in the parasagittal view where the 
entire length of the lateral ventricle is visualised; this is shown in figures 18 and 19. It 
was taken as a vertical distance measured immediately adjacent to the caudothalamic 
notch, from the floor of the lateral ventricle to the uppermost wall of the lateral 
ventricle.    
Fig 17: MRI mid-coronal view showing 
measurement of the anterior horn width 
 
 
Fig 16: CUS mid-coronal view showing 
measurements of the anterior horn width 
Fig 14: CUS mid-sagittal view the showing linear 
measurements of the genu, depth and splenium 
of the corpus callosum taken in the anterior, 
middle and posterior orientations  
Fig 15: T1 weighted MRI in mid-sagittal view 
showing linear measurements of the genu, depth 
and splenium of the corpus callosum taken in the 
anterior, middle and posterior orientations  
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6.1 MR image acquisition 
MR images were acquired from a Philips Achieva 3 Tesla (Philips Medical Systems, 
Best, Netherlands) shown in figure 18 below. 
Fig 20 Philips Achieva 3 Tesla MRI scanner 
 
 
Conventional MR imaging with T1 weighted (T1W) and T2 weighted (T2W) images were 
taken in coronal, axial and parasaggital views. Together with the conventional imaging, 
diffusion weighted images (DWI) were also taken (Scherzinger and Hendee 1985; 
Gibby 2005). 
Fig 19: MRI parasaggital view 
showing the measurement of the 
midbody height of the lateral 
ventricle 
 
 
 
Fig 18: CUS parasaggital view 
showing the measurement of the 
midbody height of the lateral 
ventricle 
Fig 20: Neonatal unit MRI scanner at Queen Charlotte’s & Chelsea 
Hospital (www.imperial.nhs.uk/discoveryscanning) 
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MRI was performed on a Philips 3-Tesla system (Philips Medical Systems, 
Netherlands) using an 8-channel phased array head coil. The 3D Magnetization 
Prepared Rapid Gradient Echo (MPRAGE) and high-resolution T2-weighted fast spin 
echo images were obtained before diffusion tensor imaging. Data were acquired with a 
SENSE factor of 2, and the scanning time for the sequence was 5 minutes. 
Table 5 Sequences used during MRI scanning 
MRI sequence Reconstructed Voxel 
size MPS (mm) 
Scan Time (min) Slice 
Thickness 
(mm) 
Actual TR/TE 
(ms) 
T1 saggital 0.82/0.82/0.50 
 
7:41.9 6 17/4.6 
T2 sense axial 
 
0.86/0.86/2.00 3:22.6 2 14473/160 
MRI stands for magnetic resonance imaging, MPS stands for measurement, phase and slicing and act TR/TE stands for actual 
repetition time and time echo  
 
6.2 CUS image acquisition 
I performed cranial ultrasound imaging using a Toshiba Diagnostic Ultrasound System 
(Aplio MX, Model SSA-780A) with a frequency of 7.0 Hz through the anterior 
fontanelle. The images were taken in the standard 6 coronal planes: at the levels of 
the frontal lobes, frontal horns of the lateral ventricles, through the foramen of Munro 
and 3rd ventricle, bodies of the lateral ventricles and cerebellum, trigone of the lateral 
ventricles and through the parietal and occipital lobes (see figures 21 to 26). The 
sagittal views taken were: the mid-sagittal in the midline and parasagittal planes, one 
through the trigone of the lateral ventricle and through the insula, on either side (see 
figures 27 to 29).   
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Fig 21 CUS through the frontal 
lobes: showing the frontal lobes 
(FL), interhemispheric fissure (IHF), 
skull and orbit 
Fig 22 CUS through the frontal 
horns of the lateral ventricles: 
showing IHF, FL, frontal horns of 
the lateral ventricles caudate 
nucleus, Basal Ganglia (BG), 
temporal lobe, Sylvian fissure. 
 
Fig 23 through the foramen of Munro 
and the 3rd ventricles: showing IHF, 
temporal lobes, Sylvian fissure, the 
body of the lateral ventricle, choroid 
plexus, 3rd ventricle, thalamus and 
hippocampal fissure 
 
Fig 24 through the bodies of the 
lateral ventricles: showing IHF, FL, 
frontal horn of the lateral ventricles, 
caudate nucleus, temporal lobe, 
Sylvian fissure, corpus callosum 
(CC), cavum septum pellucidum 
(CSP), 3rd ventricle, cingulate sulcus 
 
Fig 27 CUS mid-sagittal view: 
showing the CC, thalamus, 
cerebellar vermis, 3rd ventricle, 
pons, brainstem, frontal and parietal 
lobes 
 
Fig 28 CUS parasagittal view: 
showing the lateral ventricle 
trigone, choroid plexus, caudate 
nucleus, thalamus, frontal, 
temporal, parietal and occipital 
lobes 
 
Fig 25 through the trigone of the 
lateral ventricles: showing IHF, 
trigone of the lateral ventricles, 
choroid plexus, CC, temporal lobes, 
parietal lobes. 
 
Fig 29 CUS parasagittal view through 
the insula: showing the insula, 
Sylvian fissure, frontal, temporal, 
parietal and occipital lobes 
 
Fig 26 through the occipital lobes: 
showing IHF, parietal lobes, 
occipital lobe, parieto-occipital 
fissure, calcarine fissure 
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6.3 Image analysis 
On both MRI and CUS the length, anterior midbody depth, genu and the splenium 
depths of the corpus callosum were measured in the sagittal view. In addition, the 
width of the anterior horns of the lateral ventricles in the coronal view and the midbody 
height of the lateral ventricles in the sagittal view were measured. I carried out the 
CUS analysis and performed the measurements offline, using the Osirix Dicom viewer 
software. Dr Ederies, a neuroradiologist, analysed the MR images, assigned an overall 
white matter score, and took linear measurements using the ViewForum (Philips, Best, 
The Netherlands) software.  
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7 Statistical analysis 
The analysis was done using the statistical program Stata (version 11, StataCorp LP, 
College Station, Texas). I used histograms to visually assess the distribution of the 
CUS and MRI data. I used linear regression modelling to test if the two measurements, 
obtained from MRI and CUS, were related. Assuming that MRI measurements were 
more reliable than CUS, I performed an ordinary least squares (OLS) regression 
where MRI was the independent variable (X) and CUS the dependant (Y) variable. I 
tested for a relationship between the CUS and MRI using a correlation coefficient or 
Pearson’s r value. I used a p-value to assess if that relation was due to chance or not. 
In addition, I determined the strength of the relationship using the R2 value or 
coefficient of determination.  
In principle, measurements by both MRI and CUS are prone to errors and therefore 
OLS regression analysis may be an inappropriate test to use for this study and 
therefore further analysis of the data was done using the reduced major axis (RMA) 
regression. Unlike OLS regression analysis, where the regression finds the line that 
minimizes the sum of the squares of the vertical distance between the observed and 
the estimated value; RMA minimizes the triangular area between the observed and 
estimated values and the regression line, i.e. vertical and horizontal deviations from 
the regression line, as demonstrated in figures 30 and 31 below. Therefore OLS was 
used as the primary regression model and RMA regression analysis was performed as 
a confirmatory test. 
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Fig 30 Example of OLS regression             Fig 31 Example of RMA regression 
 
        
                                                                                                                           
 
In a preliminary analysis of these data looking at the left anterior horn width (L.AHW) 
shown in figure 32, the CUS measurement (cL.AHW) was plotted in the Y-axis and the 
MRI measurement (mL.AHW) on the X-axis. The simple linear regression or ordinary 
least squares (OLS) regression is shown in green and the RMA regression in red. 
Although both OLS and RMA regression lines pass through the sample mean ( , ), 
where  is the mean of the X value and  the mean of the Y value, the RMA 
regression is the best-fit line as it minimizes the sum of the product of X and Y 
deviations.   
Fig 32   Example of RMA versus Simple linear regression plots  
 
Fig 30: Vertical line representing 
vertical deviations of y given x from 
the from the regression line  
(google)                                                                                
 
Fig 31: Right angle triangular area 
representing vertical and horizontal 
deviations of y given x  (google) 
 
 
Fig 32: cL.AHW(mm) refers to CUS measured left anterior horn 
width in millimetres and mL.AHW(mm) refers to MRI measured 
left anterior horn width in mm. 
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After performing the OLS regression, the CUS and MRI data were tested if they had 
the same distribution by presenting them in quantile-quantile plots (Q-Q plot). Unlike 
with histograms, where the number of bins may influence the visual perception, Q-Q 
plot presents the data quantile against the theoretical quantiles, based on the assumed 
distribution. In normally distributed data, the theoretical quantile gets plotted on the 
vertical axis and the inverse of the normal distribution gets plotted on the horizontal 
axis. These data are plotted in an ascending order. If the data were normally 
distributed or had the same distribution, the data would fall on the diagonal reference 
line (y = x). The Q-Q plot is used to assess the distribution of the raw data and 
residuals from a regression fit. An example of a Q-Q plot is demonstrated in figure 33, 
using the genu depth of the corpus callosum. This example showed the data falling on 
the reference line, which is shown in red; this suggests that the data had the same 
distribution and were normally distributed. Judging how close to the reference line the 
data are depends partly on the sample size; the larger the sample, the closer to the 
reference line are the data. Departure of data from normality may represent skewness 
or heavy tails (large kurtosis). 
Fig 33 Example of a Q-Q plot  
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Fig 33: cCC genu depth(mm) refers to the CUS measured depth 
of the corpus callosum in millimetres                                                                                      
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To assess the mean difference and limits of agreement between MRI and CUS 
measurements, I used the Bland-Altman method. This is a helpful visual assessment 
of how the two measurements agree. The smaller the difference is between the limits 
the better the agreement, however the significance of that agreement is informed by 
clinical applicability. Figure 34 shows a preliminary analysis of the measurements of 
the length of the corpus callosum. 
Fig 34    Example of a Bland-Altman Plot     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 34: cCC length(mm) refers to the CUS measured length of 
the corpus callosum in millimetres and mCC length(mm) refers 
to the MRI measured length of the corpus callosum in 
millimetres. The red lines represent the 95% confidence 
intervals and the purple line in the middle is the mean. 
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8 Results 
The measurements in this study were in millimetres as presented in Tables 6. 
Table 6 CUS imaging characteristics 
 Ant midbody depth stands for anterior midbody depth of the corpus callosum, Genu stands for genu of the corpus callosum,  
 Splenium stands for splenium of the corpus callosum, LAHW stands for left anterior horn width of the lateral ventricle, RAHW 
 stands for right anterior horn width of the lateral ventricle, LV midbody height stands for left ventricular midbody height of the 
 lateral ventricle and RV midbody height stands for right ventricular midbody height of the lateral ventricle. 
 
8.1 Assessing for measurement reliability 
I estimated measurement error by investigating intra- and interobserver variability 
using a sample of 30 CUS and MRI data taken from the same population. These 
measurements were taken by me (PN) and Dr Ederies (AE). We each took CUS and 
MRI measurements of the length of the corpus callosum at two time periods, two 
weeks apart. Measurement differences within and between observers were analysed. 
The importance of analysing inconsistencies in measurements is to help identify 
inherent methodological variability.  
Using concordance correlation coefficient (Lin 1989; Lin 2000; Barnhart, Lokhnygina et 
al. 2007), which measures the agreement between variables, the CUS inter-observer 
Characteristics Mean (SD) 
 
Range 
Length of corpus callosum (mm) 46.483 (3.835) 35.9 – 61.5 
 
Genu (mm) 3.181 (0.889) 1.18 – 5.59 
 
Ant midbody depth  (mm) 
 
2.297 (0.482) 1.20 – 3.66 
Splenium  (mm) 3.182 (0.859) 1.16 – 5.35 
 
LV midbody height (mm)  
 
2.758 (1.587) 0 – 10.96 
RV midbody height  (mm) 2.460 (1.491) 0 – 10.74 
 
LAHW (mm) 2.273 (1.356) 0 – 8.29 
 
RAHW (mm) 2.007 (1.165) 0 – 8.00 
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agreement was 0.879 and that of the MRI was 0.940. Using the Bland-Altman plot 
(Bland and Altman 1986) the mean difference in the CUS measurements was -0.136 
(range, -1.46 to 1.44) and that of MRI was -0.4 (range, -4.3 to 2.8) in relation to 
measurements of 38.0mm to 55.0mm. This difference was small in relation to the size 
of the measured structure suggesting high agreement between observers. 
8.2 Length of the corpus callosum 
There were 301 patients included in the study, however 6 could not be analysed due to 
missing MRI data; therefore a total of 295 patients were included in the analysis. The 
data on the measured length the corpus callosum by CUS and MRI were presented on 
histograms shown in figures 35 & 36 below.  
Fig 35 CUS length of corpus callosum            Fig 36 MRI length of corpus callosum      
  
Fig 37 Scatter plot length of corpus callosum 
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Data presented in a scatter plot in figure 37 had a positive linear orientation between 
CUS measured length of the corpus callosum and MRI measurements. The ordinary 
least squares (OLS) regression analysis in figure 38 showed a significantly positive 
linear relationship between the length of the corpus callosum as measured by CUS to 
that measured by MRI with R2=0.842, p=0.000. The reduced major axis (RMA) 
regression analysis showed a similar result to OLS with the best-fit line having a slope 
of 0.981 as shown in figure 39. These data showed that CUS measurements of the 
length of the corpus callosum were comparable to MRI. As presented in the Q-Q plot 
in figure 40, these data were normally distributed.  
Fig 38 Linear regression on length of corpus callosum     Fig 39 RMA regression on length of corpus callosum                
  
Fig 40 Q-Q plot CUS length of corpus callosum   
 
There was a small difference in the measurements between the CUS and MRI in 
relation to the length of the corpus callosum, suggesting that measurements by the 
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CUS were as reliable as those from MRI; this is demonstrated in figure 41 below. The 
95% limits of agreements ranged from -1.182 to 5.045 and the mean difference was 
1.931 (95% CI, 1.753 to 2.110).  
Fig 41 Bland-Altman plot on length of the corpus callosum 
 
8.3 Depth of the corpus callosum 
Histograms of CUS and MRI measurements of the depth of the corpus callosum were 
normally distributed as demonstrated in figures 42 and 43.  
Fig 42 CUS depth of corpus callosum        Fig 43 MRI depth of the corpus callosum
  
There was a weakly positive linear association between CUS and MRI measurements 
of the anterior midbody depth of the corpus callosum (Pearson’s r 0.290) as 
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demonstrated in figure 44. Simple linear regression model accounted for only 8.4% of 
the variance (R2=0.084, p>0.000), however the reduced major axis (RMA) regression 
analysis showed a strong positive linear relationship with a slope of 1.092 as shown in 
figure 45 below. The analysis showed this to be an unreliable measurement due to the 
poor fit of the data to the regression models. 
Fig 44 OLS depth of corpus callosum                Fig 45 RMA regression depth corpus callosum    
       
To estimate the true error from this regression model, I computed residual regression 
analysis. The residuals were randomly distributed around the mean of zero; 
suggesting that the variances of the error are equal as shown in a histogram in figure 
46 and scatter plot in figure 47. However, the Q-Q plot presented in figure 48 looked 
poor and does not give much confidence in the statistical model.   
Fig 46 CUS Residuals depth corpus callosum     Fig 47 CUS residuals of depth of corpus callosum           
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Fig 48 Q-Q plot CUS depth of the corpus callosum                                   
 
Although there was a numerically small difference between the measurements of the 
CUS and the MRI, in relation to the size of the measured structure, this difference was 
significant. The 95% limits of agreements ranged from -0.933 to 1.075 with a mean 
difference of 0.071 (CI 0.013 to 0.129) as shown in figure 49 below.  
Fig 49 Bland-Altman plot of the depth of the corpus callosum 
 
Table 7 below showed the unreliability of the measurements of the genu and the 
splenium of the corpus callosum due to poor fit to the regression model.  
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Table 7 Results of the linear regression and Bland-Altman analysis 
Measure OLS R2 RMA 
slope 
Min 
difference 
(mm) 
Max 
Difference 
(mm) 
Mean 
Difference 
(95% CI) 
Limits of 
agreement 
(mm) 
Genu 0.02 1.06 1.68 5.12 0.11 
(-0.01 to 0.23) 
-2.02 to 2.24 
Splenium 0.08 1.12 0.80 4.77 -0.04 
(-0.15 to 0.06) 
-1.84 to 1.77 
Genu stands for genu of the corpus callosum, Splenium stands for splenium of the corpus callosum, CI stands for confidence 
interval, OLS stands for ordinary least squares regression, RMA stands for reduced major axis regression; Min stands for 
minimum, Max stands for maximum  
8.4 Left anterior horn width of the lateral ventricles 
Of the 301 observations, 11 were missing and 290 were analysed. The data were 
nearly normal in distribution as shown in the histograms in figures 50 and 51. There 
was a moderately strong positive linear association between the CUS and MRI 
measurements of the left anterior horn width (LAHW) of the lateral ventricles (r=0.637 
p>0.000). The RMA regression analysis showed a strong linear relationship between 
the CUS and MRI measurements of the LAHW with a regression line slope of 0.987 as 
shown in figure 52. The Q-Q plot however looked poor and did not give much 
confidence in the model, as shown in figure 53. 
Fig 50 Histogram of CUS left anterior horn width   Fig 51 Histogram MRI left anterior horn width              
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Fig 52 RMA regression left anterior horn width    Fig 53 Q-Q plot left anterior horn width                                
       
This group analysis suggested that the CUS and MRI measurements were 
comparable, as there was a small difference between them. However, such a small 
difference in size may have a clinically significant outcome on an individual patient; 
therefore they would have to be interpreted with caution. The 95% limits of agreement 
varied from 0.035 to 8.495 with a mean difference of -0.260 (CI -0.381 to -0.140) as 
shown in figure 54.  
Fig 54 Bland-Altman plot of left anterior horn width 
 
8.5 Right anterior horn width of the lateral ventricles 
The data were nearly normally distributed as presented in the histograms in figures 55 
and 56 and were therefore analysed as normally distributed data. There was a 
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moderately strong positive linear association between the CUS and MRI 
measurements of the right anterior horn width (RAHW) of the lateral ventricles, 
r=0.663 p>0.000. The regression model showed a strong positive linear relationship 
with a slope of 0.946 as demonstrated in figure 57. However, the Q-Q plot as shown in 
figure 58 was poor and did not give much confidence in the model.  
Fig 55 Histogram CUS right anterior horn width      Fig 56 Histogram MRI right anterior horn width 
   
Fig 57 RMA regression of right anterior horn width     Fig 58 Q-Q plot of the right anterior horn width                    
   
There was a small difference in measurements between the CUS and MRI, however 
these results would have to be interpreted with caution in clinical settings as a small 
measurement difference may be clinically significant for an individual patient due to the 
size of the lateral ventricles in relation to the difference in measurement. The 95% 
limits of agreements ranged from -2.441 to 1.545 with a mean difference of -0.448 (CI -
0.563 to -0.333) as demonstrated in figure 59.  
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Fig 59 Bland-Altman plot of right anterior horn width 
 
8.6 Right midbody height of the lateral ventricles 
The data were nearly normally distributed as demonstrated in the histograms in figures 
60 and 61 and were analysed as such. The CUS and MRI measurements of the right 
midbody height had a strong positive relationship with a slope of 1.034 as 
demonstrated in figure 60. The Q-Q plot presented in figure 63 however was poor and 
did not give much confidence in the model.  
Fig 60 CUS histogram right ventricular midbody height   Fig 61 MRI histogram right ventricular midbody height 
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Fig 62 RMA regression of right midbody height        Fig 63 Q-Q plot of right ventricular midbody height
   
There was agreement between the CUS and MRI measurements. The 95% limits of 
agreement ranged from -2.917 to 1.327 with a mean difference -0.795 (95% CI, -0.917 
to -0.673) as presented in figure 64 below. However this small difference in 
measurements may be clinically significant for an individual patient. 
Fig 64 Bland Altman Plot Right ventricular midbody height 
 
8.7 Left midbody height of the lateral ventricles 
The data were nearly normally distributed as presented on figures 65 and 66 and were 
analysed as such. There was a strong positive linear association (Pearson’s r 0.802, 
p=0.000) and a moderate positive linear relationship (R2 = 0.643). The RMA 
regression analysis showed a strongly positive linear relationship with a slope of 1.049 
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as demonstrated in figure 67. The residual regression analysis presented in the Q-Q 
plot on figure 68 was poor and did not give much confidence in the models.  
Fig 65 CUS left ventricular midbody height    Fig 66 MRI left ventricular midbody height 
   
 Fig 67 RMA regression of left ventricular midbody height    Fig 68 Q-Q plot of MRI left ventricular midbody height        
   
The limits of agreement between the CUS and MRI were small, which suggested 
agreement between the two tests. The 95% limits of agreement ranged from -2.776 to 
1.647 with a mean difference of -0.564 (95% CI -0.693 to -4.36) as demonstrated in 
figure 69. This small difference may have clinical implications for an individual patient, 
which may not be evidence in a group analysis; therefore these results are to be 
interpreted with some caution. 
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Fig 69 Bland Altman Plot Left Ventricular Midbody height 
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Study 3 
9 Neurodevelopmental outcome 
There were 301 participants in the study, however at the end of data collection, a 
subset of 156 had Bayley scale of infant and toddler development third edition 
assessment. Of the 156 participants with neurodevelopmental assessment, 6 could not 
be analysed due to incomplete MRI/CUS data; therefore a total of 150 participants 
(49.8% of the original cohort) were included in the analysis.  
9.1 Neurodevelopmental assessment 
Bayley scale of infant and toddler development (BSID 3rd edition) assessment was 
performed at a mean of 20 months corrected age. Drs Shona Falconer and Andrew 
Chew, who performed the BSID 3rd assessment, were blinded to clinical and imaging 
data. The BSID 3rd edition tool is used to assess infants from ages 0 to 3 years and it 
assesses five main developmental domains: cognitive, language (receptive and 
expressive skills), social-emotional, motor (fine and gross motor skills), and adaptive-
behavioural development. Three main scales directly assess the child’s performance: 
cognitive (comprising of 91 items), motor (comprising of 66 fine motor and 72 gross 
motor items) and language (comprising of 48 expressive and 49 receptive items) 
scales. The other two scales are conducted by administering questionnaires to 
caregivers or parents.  
The starting point for the assessment in the language, motor and cognitive domains is 
determined by the child’s age. To establish the base level, the first three starting items 
must be correct; if a child fails to score, the examiner must administer items from an 
earlier starting point and continue until a ceiling is reached. Assessment at each 
domain starts at an age-determined starting point.  Repeat administration of items in 
 76 
an assessment is not allowed, however if a correct response to a previously tested 
item is observed during a testing of a different domain, the child gets a score for that 
previously failed item. For each test item achieved in the motor, cognitive and 
language domains, the child is given a score of one and items failed are given a score 
of zero. If a child scores zero for five consecutive items, then a ceiling is said to have 
been reached and testing stops. Raw scores obtained from these domains are 
converted into scale scores and then composite scores. 
Composite scores are used to assess a child’s developmental performance against the 
norms of children of the same age who are developing normally. The composite motor, 
cognitive and language scores have a mean of 100 and standard deviations of 15. The 
composite cognitive scores range from 55 to 145, composite language scores range 
from 47 to 153 and composite motor scores range from 46 to 154. The BSID 3rd edition 
assessment, depending on the child, can take 60 to 90 minutes to administer. The 
primary aim of the assessment is to identify children with developmental delay. Scores 
of 130 or more are deemed very superior, 120 to 129 as superior, 110 to 119 high 
average, 90 to 109 as average, 80 to 89 low average, 70 to 79 as borderline and score 
of 69 or below are extremely low.  
For this study, BSID 3rd edition was chosen to allow comparison of our data with 
current literature and that it allowed corrected age for prematurity to be used as the 
appropriate start age for assessment. The motor and cognitive domains were analysed 
against the imaging data. The cranial ultrasound measurements with the strongest 
linear relationship were analysed against the composite motor and cognitive scores. 
The length of the corpus callosum and lateral ventricular midbody heights (left and 
right) were analysed against the composite motor and cognitive scores. The outcome 
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of interest was developmental delay defined as composite motor or cognitive score of 
70 or less. The composite scores below 70 were selected for the study in order to 
detect the severe forms of neurodevelopmental delay. Composite motor and cognitive 
scores of 70 or less were designated one and scores more than 70 were designated 
zero.  
9.2 Statistical analysis 
I utilised logistic regression analysis to test if the presence of a particular outcome 
could be explained by the independent variable. Unlike in linear  regression where 
both the dependent (Y) and independent (X) variables are continuous, in logistic 
regression the dependent variable is binary (0,1), but the independent variable can be 
continous or dichotomous. Although the simple logistic regression equation is based 
on a linear relationship between the dependent and the independent variables, logit 
transformation is applied on the dependent variable. The dependent variable, the 
natural log of odds of the outcome has an equation: Log (odds) = logit (p)  = ln [p/(1-
p)], where ln is the natural log of the outcome, p the probability for presence of the 
outcome and 1-p the probability for absence of the outcome. Probability p can be 
transformed into odds by the equation:  
p = odd/(1+odds) = eβ0+β1x /(1+ eβ0+β1x)  = β0 +β1x;   
where β0 (intercept) is the overall outcome risk, β1 (slope) is the fraction by which the 
outcome risk is altered by a unit change in the independent variable x.  
Receiver operating characteristic (ROC) curve is a measure of accuracy of the test in 
discriminating an event (outcome) from a non-event (absence of that outcome). It plots 
the true positive rate (sensitivity) on the Y axis against the false positive rate (1-
specificity) on the X axis. Each data point on the ROC curve represents a sensitivity 
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and 1-specificity dyad corresponding to the various cut-off points. These values are 
plotted and joined together to form the ROC curve. The aim of the ROC curve is to find 
a cut-off point that minimizes false positives and false negatives and maximizes 
sensitivity and specificity. The best cut-off point is the one closest to the left upper 
corner of the ROC curve as shown in the example in figure 70 (obtained from google 
search). A non-discriminating test will have an equal number of true and false 
positives, and will lie on or close to the 450 reference line. The  area under the curve 
(AUC) measures the overall accuracy of the test in discriminating between presence 
and absence of the outcome  (Swets 1988; Swets, Dawes et al. 2000). 
Fig 70  Example of a Receiver Operating Characteristic (ROC) curve 
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9.3 Results 
The cranial ultrasound measurements with a strong linear relationship with MRI were 
the length of the corpus callosum and ventricular midbody height. These analyses 
represent 150 subjects who had the CUS measurements (independent variables) as 
well as motor and cognitive outcomes (dependent variable). The distribution of the 
composite motor and cognitive scores are represented in figures 71 and 72 
respectively. Presence of motor or cognitive delay were coded as 1 and their absence 
as 0. There were 3 predictors or independent variables and therefore 3 degrees of 
freedom. Using the logit command, the β coefficient was produced. Using the logistic 
command, stata exponentiated the β coefficient which gave the odds of developmental 
delay. The odds ratio (OR) with 95% confidence intervals were computed as the odds 
of developmental delay in those affected divided by the same odds in the unaffected 
group.  
Fig 71 Histogram on motor scores            Fig 72 Histogram on cognitive scores               
   
9.3.1 Motor outcome 
An increase in the length of the corpus callosum was associated with a reduced risk of 
developing motor delay. The odds ratio (OR) for the length of the corpus callosum 
showed that for every unit increase in the length of the corpus callosum, the odds of 
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developing motor delay were 0.840 times lower. The ROC curve had an area under 
the curve (AUC) of 0.615; suggesting that the length of the corpus callosum was not 
accurate at discriminating motor delay as demonstrated in figure 73.   
Fig 73 Length of corpus callosum and motor delay   Fig 74 Left ventricular midbody height and motor delay 
  
The left ventricular midbody height was better at discriminating motor delay, although 
this did not reach significance as demonstrated in table 8 and Fig 74. 
Table 8 Logistic regression analyses for motor outcome 
 
      LV midbody height stands for left ventricular midbody height of the lateral ventricle and RV midbody height stands for  
      right ventricular midbody height of the lateral ventricle measured in millimetres, AUC stands for area under the curve. 
9.3.2 Cognitive outcome 
An increase in the length of the corpus callosum was associated with a reduced risk of 
developing cognitive delay. The odds ratio (OR) for the length of the corpus callosum 
showed that every unit increase in the length of the corpus callosum was associated 
with a 0.875 times fewer odds of developing cognitive delay. The ROC curve though 
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Left ventricular midbody height as predictor of motor delay
Motor Delay 
CUS imaging findings  Odds Ratio 95% CI P>|z| AUC 
Length of the corpus 
callosum (mm) 
0.840 0.710 – 0.995 0.044 0.615 
LV midbody height (mm) 1.477 1.093 to 1.997 0.011 0.770 
RV midbody height (mm) 1.361 0.995 to 1.861 0.054 0.638 
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showed that the length of the corpus callosum was not accurate at discriminating 
cognitive delay, AUC was 0.587 as demonstrated in figure 75.   
Fig 75 Corpus callosal length and cognitive delay     Fig 76 Left ventricular midbody height and cognitive delay 
 
Ventricular midbody height was better at discriminating cognitive delay, although this 
did not reach significance. This is demonstrated in figure 76 and table 9. 
Table 9 Logistic regression analyses for cognitive outcome 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  LV midbody height stands for left ventricular midbody height of the lateral ventricle and RV midbody height stands for 
  right ventricular midbody height of the lateral ventricle measured in millimetres. CI stands for confidence intervals, AUC  
  stands for area under the curve 
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Cognitive Delay 
CUS imaging 
findings 
Odds Ratio 95% CI P>|z| AUC 
Length of the corpus 
callosum (mm) 
0.875 0.742 to 1.031 0.110 0.588 
LV midbody height 
(mm) 
1.423 1.056 to 1.914 0.020 0.720 
RV midbody height 
(mm) 
1.406 1.026 to 1.928 0.034 0.680 
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10 Discussion 
In order to determine whether CUS could be used to detect white matter disease more 
precisely, I investigated how quantitatively comparable linear measurements of the 
white matter using CUS and MRI were. I sought to find a simple bedside measure of 
white matter disease that clinicians would use in making prognostic decisions. I chose 
to measure the corpus callosum, a marker of brain connectivity and size of the lateral 
ventricles, a reasonable measure of white matter loss. White matter is formed by 
oligodendrocytes through formation of myelin. Preterm birth disrupts the myelination 
process by apoptosis and dysmyelination leading to hypomyelination. As a result a 
reduced amount of white matter is formed making the cerebral ventricular system 
prone to dilatation.  
It is conceivable that white matter injury would affect corpus callosal growth, not only 
by thinning as is often reported on the literature, but also in shortening; and that 
increases in ventricular size may reflect some degree of white matter injury. I therefore 
took linear measurements of the length and thickness of the corpus callosum, as well 
as linear measurements of the lateral ventricles using both CUS and MRI in each 
subject.   
I found CUS measurements of the length of the corpus callosum highly comparable to 
those taken by MRI. Similar findings have previously been reported: in a study of 
fetuses that sought to characterise growth of the corpus callosum from 18 to 37 weeks 
gestations. MRI was used to measure the length of the corpus callosum and its 
subdivisions. The MRI results were compared to historic fetal ultrasound results. The 
study reported a significant positive correlation between the CUS and MRI 
 83 
measurements of the length of the corpus callosum (Harreld, Bhore et al. 2011). 
Another but smaller study of preterm born infants, born before 33 weeks gestation (N = 
26) and term born controls (N = 8), performed CUS and MRI scans on the same day in 
the majority of subjects. Linear measurements of cerebral structures, including the 
corpus callosum were taken. In that study there were no significant differences in the 
measurements of the length of the corpus callosum reported (Leijser, Srinivasan et al. 
2007).  
Very few studies in the current literature compare linear measurements of cerebral 
structures, especially those of the corpus callosum, using CUS and MRI; and none 
report on the neurodevelopment at 2 years corrected age using Bayley Scale of Infant 
and Toddler Development, 3rd edition. Many studies measuring the corpus callosal 
size employ different methods: linear measurements using CUS (Anderson, Warfield 
et al. 2004; Anderson, Laurent et al. 2005; Anderson, Laurent et al. 2006; Perenyi, 
Amodio et al. 2013) or some measure of cerebral structure size using MRI 
(Rademaker, Lam et al. 2004). One study looked at the growth rate of the corpus 
callosum, in preterm infants born before 33 weeks gestation, measured the length of 
the corpus callosum on days 4 to 7, at 6 weeks and term age using CUS, found that 
the psychomotor developmental index (PDI) and mental developmental index (MDI) 
scores of 85 to 100 were associated with a longer mean corpus callosum length 
compared to PDI and MDI of 70 to 85 (Rademaker, Lam et al. 2004; Anderson, 
Laurent et al. 2005; Anderson, Laurent et al. 2006). In another study, the authors 
found that a slower growth rate was associated with a shorter corpus callosum and 
poorer motor development; however these were fewer in number. This impaired 
growth of the corpus callosum was found to be associated with white matter disease 
(Anderson, Laurent et al. 2005; Anderson, Laurent et al. 2006). It was with this in mind 
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that we sought to precisely measure the length of the corpus callosum and investigate 
its effect on motor and cognitive development around 20 months corrected age. 
A recent study used MRI to measure the length of the corpus callosum in preterm 
infants at term age and found that a short corpus callosum was associated with a high 
risk of cerebral palsy and cognitive impairment (MDI <70) at 2 years corrected age 
using Bayley scale of infant development 2nd edition (Park, Yoon et al. 2013). While 
another study measured the cross sectional area of the corpus callosum on MRI as a 
function of motor outcome in preterm infants, born before 33 weeks gestation and term 
controls at 7 to 8 years of age. They found that preterm infants had significantly 
smaller total length, body and splenial areas of the corpus callosum compared to term 
born children and that there was a strong association between the total area of the 
corpus callosum and motor function. A smaller corpus callosum was associated with 
poorer motor function and larger corpus callosum was associated with better motor 
function (Rademaker, Lam et al. 2004). Some authors measured the ratio of the length 
of the corpus callosum to the splenium and midbody in preterm born infants with 
diplegia compared to neurologically normal control group, and found the ratio to be 
significantly smaller among the cerebral palsy children (Iai, Tanabe et al. 1994).  
Conversely, some studies found no relationship between the length of the corpus 
callosum and neurodevelopmental outcome in the short and long term (Cooke and 
Abernethy 1999; Perenyi, Amodio et al. 2013). The recent study by Perenyi et al, 
looked at African-American preterm infants born before 37 weeks gestation and 
performed linear measurements of the length and thickness of the corpus callosum 
using CUS. This study found that these measurements did not provide anymore value 
than morbidities in predicting neurodevelopmental outcome and therefore concluded 
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that these measurements were not beneficial (Perenyi, Amodio et al. 2013). The study 
by Cooke et al, performed MRI in teenagers aged 15 to 17 years, born with very low 
birth weight and measured the length of the corpus callosum in addition to measuring 
area of the corpus callosum and its subdivisions. The corpus callosum was found to be 
relatively smaller in the study group compared to the control group; however there was 
no association found between the measurements of the corpus callosum and school 
performance (Cooke and Abernethy 1999). Although no direct comparison can be 
made between our study and these, to my knowledge, our study is the first to compare 
linear measurements of the length of the corpus callosum using MRI and CUS and use 
Bayley Scale of Infant and Toddler development 3rd edition for neurodevelopmental 
assessment. We showed a strong agreement between the CUS and MRI 
measurements of the length of the corpus callosum, surprisingly these were not 
accurate at discriminating motor and cognitive delay. 
There was a weak linear relationship between the CUS and MRI measurements of the 
anterior midbody depth of the corpus callosum in our study in spite of there being a 
small difference between these measurements; we therefore concluded that this 
measurement was unreliable. It therefore was not surprising that these measurements 
were not accurate at picking up motor or cognitive delay. This however is in contrast to 
findings by Leijser et al discussed earlier, who found no difference in the 
measurements of the anterior midbody depth of the corpus callosum between CUS 
and MRI, suggesting a much stronger linear relationship between the two methods; 
however there was no neurodevelopmental outcome reported (Leijser, Srinivasan et 
al. 2007). Others have also found no association between the thickness of the corpus 
callosum and future neurodevelopmental outcome (Cooke and Abernethy 1999; 
Anderson, Laurent et al. 2006; Perenyi, Amodio et al. 2013). Cooke et al 1999, 
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investigating the effect of white matter injury and subsequent neurological impairment 
among adolescents born with a very low birth weight examined by MRI between the 
ages of 15 and 17 years, also found no association between white matter injury 
including thinning of the corpus callosum and later school performance. They 
concluded that the neurological impairment often seen in this population is due to poor 
postnatal growth rather than white matter injury (Cooke and Abernethy 1999). The 
Perenyi et al study, also measured the thickness of the corpus callosum using CUS as 
described earlier and concluded that thickness of the corpus callosum had no added 
advantage to preterm morbidities in predicting neurodevelopmental outcome (Perenyi, 
Amodio et al. 2013).  
The association of the thinning of the corpus callosum to long-term motor and 
cognitive outcome as reported in the literature varies, due in part to differences in 
study design (Mercuri, Jongmans et al. 1996; Sheth, Schaefer et al. 1996; Cooke and 
Abernethy 1999; Stewart, Rifkin et al. 1999; Rademaker, Lam et al. 2004). In the 
literature, the splenium of the corpus callosum has previously been reported to have 
particular susceptibility to thinning among individuals born preterm (Stewart, Rifkin et 
al. 1999; Peterson, Vohr et al. 2000; Nagy, Westerberg et al. 2003). Anderson et al 
measured thickness of the corpus callosum at the splenium using the posterior fontalle 
as the acoustic window in preterm infants born before 33 weeks gestation at term age 
and compared this measurement to MRI white matter volume; they found no 
relationship between the splenium thickness on CUS and the white matter volume on 
MRI (Anderson, Warfield et al. 2004). However in the same study by Rademaker et al 
discussed earlier, the area measurements of the anterior, middle and posterior corpus 
callosum were shown to be strongly associated with motor function (Rademaker, Lam 
et al. 2004). In our study in spite of a strong linear relationship between CUS and MRI 
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measurements of the genu and splenium depths of the corpus callosum, these 
measurements were not accurate at picking up motor or cognitive delay and therefore 
strengthening the conclusion of the thickness of the corpus callosum as a poor 
discriminator of neurodevelopmental impairment.  
Linear measurements of the lateral ventricles 
In our study, there was a strong linear relationship between the CUS and MRI 
measurements of the lateral ventricles; however the anterior horn width measurements 
were not accurate at detecting motor or cognitive delay. Although the ventricular 
midbody height measurements, left more than right, were better at discriminating 
neurodevelopmental delay, these did not reach significance. Interestingly the study by 
Horsch et al investigating linear ventricular size measurements using CUS and 
ventricular volume using MRI in infants born before 27 weeks gestation at term age 
found the left ventricular volume to be larger than the right in extremely preterm infants 
at term; however this study did not report on the outcome of the infants (Horsch, 
Bengtsson et al. 2009).   
As far as I know, ours is the first study that compared linear measurements of the 
lateral ventricles using CUS and MRI and compared them to neurodevelopmental 
outcome at 2 years corrected age using BSID 3rd edition. Most studies in the literature 
investigated reference ranges at various gestational ages; all of which found CUS to 
be a reliable measure of ventricular size albeit the study by Sondhi et al showing much 
narrower confidence intervals and proportional increase in ventricular size with 
increasing gestation (Levene 1981; Reeder, Kaude et al. 1983; Perry, Bowman et al. 
1985; Liao, Chaou et al. 1986; Brann, Qualls et al. 1990; Davies, Swaminathan et al. 
2000; Sondhi, Gupta et al. 2008; Brouwer, De Vries et al. 2010; Brouwer, de Vries et 
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al. 2012) . Other studies investigated lateral ventricular volume as a measure of 
ventricular size either directly or indirectly (Csutak, Unterassinger et al. 2003; Horsch, 
Bengtsson et al. 2009) and some looked at ratios of ventricular and brain size (Giedd, 
Rumsey et al. 1996; Giedd, Snell et al. 1996; Maunu, Lehtonen et al. 2011; Antes, 
Kiefer et al. 2012). One study compared CUS measurements with those of CT scans 
and found that there was a close correlation between the two measures of ventricular 
size (London, Carroll et al. 1980).  
A recent study compared 2D to 3D CUS measurements of the lateral ventricles in 
neonates scanned between days 3 and 146 days (mean of 24 days). The authors 
measured ventricular depth (anterior horn width) using the Davies method (Davies, 
Swaminathan et al. 2000) and ventricular index using the Levene method (Levene 
1981) in 40 babies with normal sized lateral ventricles. The mean difference between 
the 2D and 3D measurements of the ventricular depth was minimal (McLean, Coombs 
et al. 2012). Although this study differed from ours methodologically: the study 
compared 2D and 3D CUS, gestational ages of these babies were not stated and there 
were fewer patients (N=40) and the brain scans were performed over a variable period 
and there was no neurodevelopmental outcome information given; it found a close 
relationship between 2D and 3D measurements.  
Most studies in the literature use Bayley Scale of Infant Development (BSID) 2nd 
edition or another measure of neurodevelopmental outcome. The Bayley Scale of 
Infant and Toddler Development (BSID) 3rd edition is becoming increasingly used. 
However there is a growing body of evidence reporting that the BSID 3rd edition 
consistently scores higher than the BSID 2nd edition, by about 7 scores. The authors 
therefore argue that the BSID 3rd edition may underestimate risk of developmental 
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delay. The repercussions of these findings are important in neurodevelopmental 
medicine. The potential false positives of the second edition of the BSID may 
unnecessarily induce anxiety to parents of these children while the potential false 
negatives of the third edition of the BSID may falsely reassure parents. The latter is 
perhaps more detrimental in terms of human cost as these children would miss out on 
regular follow up and early intervention which may make a significant difference in their 
final developmental outcome (Glenn, Cunningham et al. 2001; Hack, Taylor et al. 
2005; Connolly, Dalton et al. 2006; Hack 2012).  
Limitations 
This study was not designed to analyse specific white matter lesions but rather the 
influence of the size of the measured structures in predicting neurodevelopmental 
outcome. Therefore, these analyses were not carried out. Analysing the data on 
underlying white matter injury in addition to linear measurements may add insights as 
to the circumstances under which linear measurement may be beneficial in a neonatal 
care setting. 
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11 Conclusions 
Cranial ultrasound and MRI can precisely measure linear measurements of the corpus 
callosum and lateral ventricles. In spite of this precision in measurement, these 
measurements were not found to be useful in discriminating for neurodevelopmental 
delay at 2 years corrected age. I therefore conclude that there is no need for clinicians 
to change current qualitative CUS training and practice. However, there remains a 
need to find a reliable CUS measure of white matter disease clinicians can use at the 
bedside to make prognostic decisions. 
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